[March 21, 2012 John Hartz Senior Assistant Chief Accountant 100 F Street, N.E. RE: Fuwei Films (Holdings) Co., Ltd. Form 20-F for the Year Ended December 31, 2010 Filed March 25, 2011 Form 20-F/A for the Year Ended December 31, 2010 Filed December 2, 2011 Response dated February 7, 2012 File No. 1-33176 Dear Mr. Hartz: Company Response Letter Staff]
[Articles of Association of China Southern Airlines Company Limited 1 Articles of Association of China Southern Airlines Company Limited 。 CHAPTER 1 GENERAL PROVISIONS Article 1 These Articles of Association are formulated in accordance with “The Company Law of the People’s Republic of China” (hereinafter referred to as the “Company Law”), “The Securities Law of the People’s Republic of China”] [List of Directors and their Role and Function The members of the board of Directors (“Board”) of China Southern Airlines Company Limited are set out below. Non-Executive Directors (Chairman) Si Xian Min Wang Quan Hua Yuan Xin An Executive Directors (President) Tan Wan Geng (Executive Vice President) Zhang Zi Fang (Executive Vice President and Chief Financial Officer) Xu Jie Bo] [China Southern Airlines Company Limited Rules of Procedure for Shareholders to Nominate a Person as a Director Chapter 1 General Provisions Article 1 Chapter 2 General provisions of directors candidates Article 2 Directors of the Company are natural persons. A person shall not be nominated or serve as a director of the Company in any one of the following circumstances:] [China Southern Airlines Company Limited Terms of Reference of Audit Committee Chapter 1 General Provisions Article 1 Article 2 The Audit Committee is a specialized working organization established by the Board which shall be mainly responsible for, among other things, reviewing the Company’s financial information and its disclosure, making recommendations on appointment and removal of the Company’s external firms, coordinating] [China Southern Airlines Company Limited Terms of Reference of Remuneration and Assessment Committee Chapter 1 General Provisions Article 1 Article 2 The Remuneration and Assessment Committee is a specialized working organization established by the Board which shall be mainly responsible for formulating evaluation criteria and conducting assessment, formulating and reviewing remuneration policies and plans of the Directors and senior management] [China Southern Airlines Company Limited Terms of Reference of Nomination Committee Chapter 1 General Provisions Article 1 Article 2 The Nomination Committee is a specialized working organization established by the Board which shall be mainly responsible for discussing and making recommendations on the candidates, selection criteria and procedures for the proposed appointment of the Directors, President and senior management and] []
[March 21, 2012 John Hartz Senior Assistant Chief Accountant 100 F Street, N.E. RE: Fuwei Films (Holdings) Co., Ltd. Form 20-F for the Year Ended December 31, 2010 Filed March 25, 2011 Form 20-F/A for the Year Ended December 31, 2010 Filed December 2, 2011 Response dated February 7, 2012 File No. 1-33176 Dear Mr. Hartz: Company Response Letter Staff]
[FORM 8-K CURRENT REPORT Date of Report (Date of Earliest event Reported): March 21, 2012 CHINA BIOLOGIC PRODUCTS, INC. Delaware 001-34566 75-2308816 (State or other jurisdiction of (Commission File No.) (IRS Employer ID No.) incorporation or organization) 18th Floor, Jialong International Building, (+86) 10-6598-3111 _______________________________________________ see Item 8.01. Other Events. CHINA BIOLOGIC PRODUCTS, INC. Chao Ming Zhao Chief Executive Officer]
[Cayman Islands (Jurisdiction of incorporation or organization) No. 387 Dongming Road Weifang Shandong People’s Republic of China, Postal Code: 261061 Lysander Lee] [I, Xiaoan He, certify that: 1. 2. Based on my knowledge, this annual report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this annual report;] [CERTIFICATION BY PRINCIPAL FINANCIAL OFFICER I, Xiuyong Zhang, certify that: 1. 2. Based on my knowledge, this annual report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period] [(1) (2) The information contained in the report fairly presents, in all material respects, the financial condition and results of operations of the Company. March 21, 2012 Xiaoan He Chief Executive Officer Xiuyong Zhang Xiuyong Zhang Chief Financial Officer]
[FORM 8-K CURRENT REPORT Date of Report (Date of Earliest event Reported): March 21, 2012 CHINA BIOLOGIC PRODUCTS, INC. Delaware 001-34566 75-2308816 (State or other jurisdiction of (Commission File No.) (IRS Employer ID No.) incorporation or organization) 18th Floor, Jialong International Building, (+86) 10-6598-3111 _______________________________________________ see Item 8.01. Other Events. CHINA BIOLOGIC PRODUCTS, INC. Chao Ming Zhao Chief Executive Officer]
[TAOMEE HOLDINGS LIMITED Paul Keung Chief Financial Officer 2]
[Cayman Islands (Jurisdiction of incorporation or organization) No. 387 Dongming Road Weifang Shandong People’s Republic of China, Postal Code: 261061 Lysander Lee] [I, Xiaoan He, certify that: 1. 2. Based on my knowledge, this annual report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this annual report;] [CERTIFICATION BY PRINCIPAL FINANCIAL OFFICER I, Xiuyong Zhang, certify that: 1. 2. Based on my knowledge, this annual report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period] [(1) (2) The information contained in the report fairly presents, in all material respects, the financial condition and results of operations of the Company. March 21, 2012 Xiaoan He Chief Executive Officer Xiuyong Zhang Xiuyong Zhang Chief Financial Officer]
[March 21, 2012 VIA EDGAR Division of Corporation Finance 100 F Street, NE Attn: Larry Spirgel, Assistant Director Reid Hooper, Attorney-Advisor Re: ATA Inc. Form 20-F for the fiscal year ended March 31, 2011; Filed June 15, 2011 File No. 1-33910 Dear Mr. Hooper: We have received the Staffs comment letter dated March 9, 2012 concerning the above referenced Form]
[TAOMEE HOLDINGS LIMITED Paul Keung Chief Financial Officer 2]
